ZDAI:NASDAQDirectBooking Technology Co., Ltd. Analysis
Data as of 2026-07-11 - not real-time
$1.95
Latest Price
8/10Risk
Risk Level: High
Executive Summary
DirectBooking Technology Co., Ltd. trades at $1.95, well below its DCF‑derived fair value of $7.72, suggesting a sizable discount. However, the stock is battling severe fundamentals – revenue has collapsed by 43%, gross margin sits at just 2.3%, operating margin is –94%, and the company posted a trailing EPS of –$7.41. The balance sheet is strained with a debt‑to‑equity ratio of 84% and a market‑cap of only $15.7 M. Technicals are mixed: price is under both the 20‑day (2.28) and 50‑day (2.26) SMAs, RSI is low at 38 indicating oversold conditions, while MACD remains bearish and volatility is extreme at >100% over 30 days. The market sentiment index reads “Extreme Greed” (94.6), yet the beta of 1.6 points to heightened sensitivity to market swings.
Given the thin trading volume, high beta, and a historic max drawdown of –87%, the stock faces pronounced risk. The lack of dividend, negative cash‑flow generation, and a sector (Engineering & Construction) exposed to regulatory and geopolitical headwinds in Hong Kong further dampen the outlook, despite the apparent price discount.
Given the thin trading volume, high beta, and a historic max drawdown of –87%, the stock faces pronounced risk. The lack of dividend, negative cash‑flow generation, and a sector (Engineering & Construction) exposed to regulatory and geopolitical headwinds in Hong Kong further dampen the outlook, despite the apparent price discount.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD and price below short‑term moving averages
- Oversold RSI suggesting limited upside
- Extreme price volatility and thin trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation gap to DCF fair value
- Continued negative earnings and high debt load
- Potential for turnaround if operational restructuring succeeds
Long Term
> 3 yearsCautious
Model confidence: 3/10
Key Factors
- Sustained revenue decline and negative profit margins
- High leverage and limited cash generation
- Elevated sector, regulatory, and geographic risks in Hong Kong
Key Metrics & Analysis
Financial Health
Revenue Growth-43.20%
Profit Margin-81.83%
ROE-207.30%
ROA-60.76%
Debt/Equity84.27
P/B Ratio0.7
Op. Cash Flow$515.1K
Free Cash Flow$5.1M
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI37.9
Support$1.68
Resistance$3.00
MA 20$2.28
MA 50$2.26
MA 200$5.12
MACDBearish
VolumeIncreasing
Fear & Greed Index94.59
Valuation
Fair Value$7.72
GradeUndervalued
TypeValue
Risk Assessment
Beta1.60
Volatility100.69%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.